"Jan. 3, 2013 -- Is weight loss one of your New Year's resolutions?
If so, you might get some valuable guidance from a new survey of more than 9,000 Consumer Reports readers who have been there, done that.
- Patient Information:
Details with Side Effects
Phendimetrazine tartrate tablets are indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction. The limited usefulness of agents of this class (see CLINICAL PHARMACOLOGY) should be measured against possible risk factors inherent in their use such as those described below.
DOSAGE AND ADMINISTRATION
Each single-scored, yellow, round tablet contains 35 mg phendimetrazine tartrate. Tablets are supplied in bottles of 100 (NDC 46672-138-10) and in bottles of 1000 (NDC 46672-138-11).
Each single-scored, blue, unimprinted round tablet contains 35 mg phendimetrazine tartrate. Tablets are supplied in bottles of 100 (NDC 46672-057-10) and in bottles of 1000 (NDC 46672-057-11).
Store at controlled room temperature 15°-30°C (59°-86°F).
Dispense in tight containers with child-resistant closures.
Manufactured by: Mikart, Inc., Atlanta, GA 30318. Rev. 05/96.
Last reviewed on RxList: 4/20/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Phendimetrazine Tartrate Information
Phendimetrazine Tartrate - User Reviews
Phendimetrazine Tartrate User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.